Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rocket Pharmaceuticals (RCKT) Other financing activities (2017 - 2020)

Rocket Pharmaceuticals (RCKT) has disclosed Other financing activities for 2 consecutive years, with $139000.0 as the latest value for Q2 2020.

  • Quarterly Other financing activities changed N/A to $139000.0 in Q2 2020 from the year-ago period, while the trailing twelve-month figure was $139000.0 through Mar 2021, up 41.84% year-over-year, with the annual reading at $237000.0 for FY2020, N/A changed from the prior year.
  • Other financing activities hit $139000.0 in Q2 2020 for Rocket Pharmaceuticals, up from $98000.0 in the prior quarter.
  • In the past five years, Other financing activities ranged from a high of $139000.0 in Q2 2020 to a low of -$3.2 million in Q4 2017.